Erytech Pharma SA (ERYP.OQ)
20.69USD
16 Apr 2018
-- (--)
$20.69
--
--
--
--
2,045
$30.48
$17.50
About
Overall
Financials
ERYP.OQ | Industry | Sector | |
---|---|---|---|
P/E (TTM): | -- | 188.22 | 33.60 |
EPS (TTM): | -- | -- | -- |
ROI: | -- | -0.74 | 13.19 |
ROE: | -- | -2.80 | 15.00 |
BRIEF-Erytech To Present Results From Phase I Trial Of Eryaspase In All And New Pre Clinical Data At Aacr 2018
* ERYTECH TO PRESENT RESULTS FROM PHASE I TRIAL OF ERYASPASE IN ALL AND NEW PRE-CLINICAL DATA AT AACR 2018 Source text for Eikon: Further company coverage:
BRIEF-Oncodesign Concludes A Partnership With Erytech In Oncology
* ONCODESIGN CONCLUDES A LONG TERM SERVICE-BASED PARTNERSHIP WITH ERYTECH IN ONCOLOGY
BRIEF-Erytech FY Net Loss Widens To 33.5 Million Euros
* REPORTED ON MONDAY FY NET LOSS 33.5 MILLION EUROS, COMPARED TO 21.9 MILLION EUROS IN 2016
BRIEF-Erytech Pharma announces pricing of global offering of 5.4 mln new ordinary shares
* ANNOUNCES PRICING OF GLOBAL OFFERING TO SPECIFIED CATEGORIES OF INVESTORS OF AGGREGATE OF 5.4 MILLION NEW ORDINARY SHARES
BRIEF-Erytech Pharma announces trading suspension of its ordinary shares on Euronext paris
* ERYTECH ANNOUNCES TRADING SUSPENSION OF ITS ORDINARY SHARES ON EURONEXT PARIS
BRIEF-Erytech Pharma 9M net loss widens to 20.8 million euros
* ANNOUNCED ON MONDAY 9M NET LOSS OF EUR 20.8 MLN VS PROFIT OF EUR 16.1 MLN YEAR AGO
BRIEF-Erytech Pharma sees U.S. IPO of up to 4.26 mln ordinary shares in form of ADSs
* Erytech Pharma SA sees U.S. IPO of up to 4.26 million ordinary shares in form of American Depositary Shares, or ADSs - sec filing